Synaptamide, endocannabinoid-like derivative of docosahexaenoic acid with cannabinoid-independent function.
about
Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system.N-Acyl amines of docosahexaenoic acid and other n-3 polyunsatured fatty acids - from fishy endocannabinoids to potential leadsAlcohol, phospholipase A2-associated neuroinflammation, and ω3 docosahexaenoic acid protection.Fetal endocannabinoids orchestrate the organization of pancreatic islet microarchitectureN-Docosahexaenoylethanolamine ameliorates ethanol-induced impairment of neural stem cell neurogenic differentiationN-docosahexaenoylethanolamine regulates Hedgehog signaling and promotes growth of cortical axons.Resolvins: Endogenously-Generated Potent Painkilling Substances and their Therapeutic Perspectives.Depletion of brain docosahexaenoic acid impairs recovery from traumatic brain injuryConcussions, Traumatic Brain Injury, and the Innovative Use of Omega-3s.Inhibition of COX-2-mediated eicosanoid production plays a major role in the anti-inflammatory effects of the endocannabinoid N-docosahexaenoylethanolamine (DHEA) in macrophagesRole of Polyunsaturated Fatty Acids and Their Metabolites on Stem Cell Proliferation and Differentiation.Polyunsaturated fatty acids and endocannabinoids in health and disease.Brain omega-3 polyunsaturated fatty acids modulate microglia cell number and morphology in response to intracerebroventricular amyloid-β 1-40 in mice.Impact of dietary fats on brain functions.Anti-inflammatory ω-3 endocannabinoid epoxides.The Eye, Oxidative Damage and Polyunsaturated Fatty Acids.Food for thought: how nutrition impacts cognition and emotion
P2860
Q21132308-5A685B96-8460-4824-B73A-66B9AAA7142FQ27011679-23988E4E-376A-4D6C-BFF1-6EFB6FFC4049Q35879838-3095EBFF-1E26-4E37-8973-0046E74077E8Q36300457-5DB27DA6-8EA1-4E07-9C3C-E71DC0BB35FEQ36421916-59891D9D-C44A-4491-B305-231B4532A63FQ36529197-6209A8A4-4B1C-4EB2-8ADC-2313E0D50D95Q37362056-D4D86EB6-C4E9-44D9-80A2-A3144D0C0739Q37520738-FE2E74F8-30D5-4792-8BBB-5E802CB3AE0BQ38907714-09001DD8-E44D-4BF5-9790-042B7AA12F77Q39000393-43E8CFA3-CB0E-422C-AB44-A2EE350BC8F7Q39368607-4D93A87C-9FE8-4AEA-A38B-F417CD2253A0Q39421016-EE928B82-A70E-4113-B785-623861621AF9Q41217789-83BA746C-19A0-4E6B-87F8-CB513849C3BCQ47290017-D7BA483A-574D-4755-9225-822BA547584FQ47948005-D0A15674-505E-4A1F-9239-FA04BF3BA74FQ55515186-856E8969-B016-4F48-831B-570F3071E991Q59118186-CB17E793-3735-4319-A4B1-A9A5352C191D
P2860
Synaptamide, endocannabinoid-like derivative of docosahexaenoic acid with cannabinoid-independent function.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Synaptamide, endocannabinoid-l ...... nabinoid-independent function.
@en
type
label
Synaptamide, endocannabinoid-l ...... nabinoid-independent function.
@en
prefLabel
Synaptamide, endocannabinoid-l ...... nabinoid-independent function.
@en
P2860
P1476
Synaptamide, endocannabinoid-l ...... nabinoid-independent function.
@en
P2093
Arthur A Spector
Hee-Yong Kim
P2860
P304
P356
10.1016/J.PLEFA.2012.08.002
P577
2012-09-05T00:00:00Z